Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction

Digestive Diseases and Sciences

Volumn 39, Issue 2, 1994, Pages 225-233

  Nakagawa, Hiroshi ^a   Shimomura, Hiroyuki ^a   Hasui, Toshimi ^a   Tsuji, Hideyuki ^a   Tsuji, Takao ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

chronic liver disease; hepatitis C virus; quantitation; reverse transcription polymerase chain reaction; RNA

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS GENOME;

ADULT; AGED; BASE SEQUENCE; FEMALE; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, VIRAL; RNA-DIRECTED DNA POLYMERASE;

EID: 0028258029     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF02090190     Document Type: Article

References (42)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
3. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
4. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
5. Diagnosis of hepatitis C. Facts and perspectives
6. Detection of hepatitis C viral sequences in non-A, non-B hepatitis
7. Detection of hepatitis C viral sequences in blood donations by “nested” polymerase chain reaction and prediction of infectivity
8. Detection of serum hepatitis C virus RNA
9. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates
10. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis
11. Suppression of hepatitis C virus RNA by interferon-α
12. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α
13. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users
14. Detection, semiquantitation and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase
15. Detection of replicative intermediates of hepatitis C. Viral RNA in liver and serum of patients with chronic hepatitis C
16. Effect of α-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: A quantitative polymerase chain reaction study
17. Analysis of cytokine mRNA and DNA: Detection and quantitation by competitive polymerase chain reaction
18. The 5′-terminal sequence of the hepatitis C virus genome
19. Detection of hepatitis C virus RNA by a two-stage polymererase chain reaction with two pairs of primers deduced from the 5′-noncoding region
20. Characterization of the terminal regions of hepatitis C viral RNA: Identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end
21. Sequence analysis of the 5′ noncoding region of hepatitis C virus
22. Anti-C100-3 antibody status, viral genomic sequences, and clinical features in chronic hepatitic patients with hepatitis C virus RNA in sera
23. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
24. Genetic variation of putative core gene in hepatitis C virus
25. Molecular Cloning
26. DNA sequencing with chain-terminating inhibitors
27. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA
28. Molecular structure of the human cytoplasmic β-actin gene: Interspecies homology of sequences in the introns
29. Avoiding false positives with PCR
30. Spot-blot hybridization assay for the detection of hepatitis B virus DNA in serum: Factors determining its sensitivity and specificity
31. Precise quantitation of hepatitis C RNA using a competitive polymerase chain reaction: correlation of clinical course with levels of circulation RNA
32. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: Increase of the virus in advanced liver disease
33. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus
34. Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: Implications for hepatitis C virus replication in infected tissue
35. Hepatocellular HCV-associated antigen and antibody: Viral specificity and relation to natural history of infection
36. Immunohistochemical detection of hepatitis C virus-infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome
37. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology
38. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line
39. The hepatitis interventional therapy group: Treatment of chronic hepatitis C with recombinant interferon alfa: a multicenter randomized, controlled trial
40. Recombinant interferon alfa therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial
41. Immunopathological manifestation of viral hepatitis C